Through a new NIH Small Business Innovation Phase IIb Commercialization (5R44MH112470) grant, we are enhancing NODA™ to be the market’s first hybrid telehealth platform.
This grant will help NODA develop and test a new system of care to accelerate autism evaluations remotely to assist all stakeholders (diagnostic clinics, referring pediatricians and affected families) as shown in the following video (1 minute):
Project will connect Primary Care providers with referring diagnostic clinics electronically, through our collaboration with Total Child Health, Inc. and its popular CHADIS (chadis.com) Pediatric Autism Screening Software Platform. CHADIS is used by > 3,000 pediatricians to help them screen young children for autism during the family’s well-child visits.
BIS engineers will be also introducing BI LIVE™ in this project – a unique realtime telehealth tool that gives clinicians better clinical documentation during a video consult. Look more for this innovation in future posts.
Starting Spring 2021, a validation study will be taking place throughout Georgia (led by Emory Autism Center), and a multi-region comparative study will research NODA’s benefits compared to conventional InPerson assessments. Research sites will be in California (Children’s Hospital of Los Angeles), Arizona (Southwest Autism Research and Resource Center), Idaho and Eastern Washington (University of Idaho’s Center for Disability and Human Development). Ascend Behavior (Texas, Colorado, Arizona) will provide additional diagnostic clinic expertise as needed.